KT032 cell injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KT032 cell injection, covering 2026-02-19 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors. [EARLY_Phase 1]